/Investor DB

Averin Capital — Full Portfolio

13 tracked investments · listed companies and verified rows first

Freenomefreenome.comin𝕏NASDAQ: FRNMOct 2015

Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon, US

Riley Ennis(Founder)inCharles Roberts(Founder)inGabriel Otte(Founder)inAdam Stone(Chief Executive Officer and Director)Michael Altman(Chief Business Officer and Director)Shmuel (Sam) M. Cohn(Chief Financial Officer)

Co-investorsRA CapitalAgent CapitalAME Cloud VenturesAndreessen HorowitzArtis VenturesAsset Management Company+15 more

Commons Cliniccommonsclinic.comMay 2026

Commons Clinic is an orthopedic care provider offering treatment for spine, joint, and sports medicine conditions, along with preventive health services such as full-body MRI and biomarker labs.

Digital HealthHealthtechWellness & FitnessAustin, US

Brad Hively(Director)inNick Aubin(Founder)inPaulo Marques Da Costa(Executive Officer, Director)Prithviraj Singha Roy(Director)in

BoardJohn Loser(Director)inDavid Berry(Director)in

Board seatTristan Hunt· per SEC Form D

Co-investorsCourtside VenturesFloating PointGaingelsNorth South VenturesSteelSky VenturesTime BioVentures+2 more

Biolinqbiolinq.comin

Biolinq develops glucose-sensing technology based on micro-array biosensors for metabolic health monitoring, including continuous glucose monitoring.

BiotechDigital HealthHardwareHealthtechMedical DevicesSan Diego, US

Jared Tangney(Co-founder)inRich Yang(Co-founder)inEdward Kliphuis(Director)

BoardDaniel Bradbury(Director)inLana Ghanem(Director)

Co-investorsAlpha Wave GlobalRiverVest Venture PartnersAble PartnersAphelion CapitalBeyond CapitalBioBrit+7 more

Candidcandidco.comin

Candid develops clear aligner technology and offers remote monitoring services for dental professionals to deliver orthodontic treatment.

ConsumerDigital HealthHealthtechMedical Devices

Nick Greenfield(Founder)in

Co-investorsA-Rod CorpBessemer Venture PartnersBeyond CapitalF-Prime CapitalFantail VenturesHanaco Venture Capital+9 more

Candid Carecandidpro.com

Candid partners with licensed dental professionals to provide clear aligners and remote orthodontic monitoring for their patients.

Digital HealthHealthtechMedical DevicesNew York, US

Nicholas Greenfield(Executive Officer, Director)Jacob Goldfield(Director)Don Kingsborough(Director)Zachary Frankel(Executive Officer, Director)

BoardJohn Elton(Director)

Co-investorsGreycroft

Hologen AIhologen.ai

A clinical-stage artificial intelligence company using Large Medicine Models to optimize drug development, especially in late-stage clinical trials.

Co-investorsGaingelsMana Ventures

Mendaeramendaera.comin𝕏

Mendaera builds robotic technology, including its Focalist System for robotic-guided access and procedures such as transplant biopsy, to help healthcare providers perform reproducible clinical procedures.

Digital HealthHealthtechMedical DevicesRoboticsSan Mateo, US

Josh DeFonzo(Founder)inJason Wilson(Founder)

Co-investorsThreshold VenturesFounders FundLux CapitalFemHealth VenturesGaingelsMana Ventures+4 more

Pine Park Healthpineparkhealth.comin

Pine Park Health is a primary care practice that delivers on-site medical care to residents of senior living communities, operating a value-based care model.

Digital HealthHealthtechLongevitySan Francisco, US

Payam Parvinchiha(Chief Medical Officer)inMike TadlockinGeorge Khasin(Founder)Yingzhe Reginald FuYoitsu Kamijo(Software Engineer)Ron Davidson(Operations)

Co-investorsBoxGroupCorrelation VenturesFirst Round CapitalFoundation CapitalGradient VenturesY Combinator+7 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AllGLP-1 Receptor Agonists & Biosensors CompanyLiquid Biopsy CompanyWorld Economic ForumxPharma AI

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.